Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 1/2 1

Status

Completed 44Unknown 19Recruiting 9Withdrawn 6Terminated 4Not yet recruiting 3Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 4Genitourinary 1Dermatologic 1

Conditions

Carcinoma, Hepatocellular 2Prostatic Neoplasms 1Pancreatic Adenocarcinoma Resectable 1Melanoma 1Cholangiocarcinoma 1Bile Duct Neoplasms 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Electroporation × Clear all
NCT04717687 2022-07-13

HOPE

Poitiers University Hospital

Phase NA Withdrawn
Gastrointestinal

Cholangiocarcinoma

NCT03337997 2021-05-06

A Pilot Study of IRE for Resectable Pancreatic Cancer

University of Saskatchewan

Phase NA Withdrawn
Gastrointestinal

Pancreatic Adenocarcinoma Resectable

NCT04404647 2021-03-26

Irreversible Electroporation of Unresectable Liver Tumors

Aalborg University Hospital

Phase NA Withdrawn
Gastrointestinal

Bile Duct Neoplasms, Carcinoma, Hepatocellular

NCT03040453 2020-11-30

IRAL

Karolinska Institutet

Phase NA Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

NCT02430649 2020-05-27

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

NCT01764009 2015-09-11

AIMM

Valerio Therapeutics

Phase 1/2 Withdrawn
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡